Literature DB >> 1884022

Enhanced detection of the t(14;18) translocation in malignant lymphoma using pulsed-field gel electrophoresis.

A D Zelenetz1, G Chu, N Galili, C D Bangs, S J Horning, T A Donlon, M L Cleary, R Levy.   

Abstract

The t(14;18) chromosomal translocation that results in the juxtaposition of the bcl-2 proto-oncogene with the heavy chain JH locus is a common cytogenetic abnormality in human lymphoma. In particular, it is seen in about 85% of follicular lymphoma (FL) and up to one-third of diffuse lymphomas (DL). The chromosome 18 breakpoints have been shown to cluster into two regions. The major breakpoint region (mbr) within the 3' untranslated region of the bcl-2 proto-oncogene accounts for approximately 60% of the cases and the minor cluster region (mcr) 30 kb 3' of bcl-2 accounts for approximately 25% of the breakpoints. Because of variability in the position of the breakpoint, detection of the t(14;18) by Southern blot analysis provides an important clonal marker for the tumor. However, conventional electrophoresis (CE) fails to detect the translocation in 15% to 25% of cases. We have applied pulsed-field gel electrophoresis (PFGE) to the detection of the t(14;18) in a series of lymphoma prospectively analyzed by CE, polymerase chain reaction (PCR), and cytogenetic analysis. PFGE readily detected t(14;18) rearrangements as indicated by comigration of bands detected with probes for the mbr region (chromosome 18) and the JH locus (chromosome 14). In a series of 40 patients with FL, this method proved to be the most comprehensive for detection of the translocation compared with standard methods; in fact, in one case only PFGE was able to detect the chromosomal rearrangement. Ten percent of the FL cases were negative by all methods tested. In a separate analysis of matched tissue specimens from cases of tumor progression of FL to diffuse lymphoma, PFGE detected a common t(14;18) rearrangement confirming a clonal origin in seven of seven cases, whereas CE detected a rearrangement in only three of seven cases. Overall, PFGE was able to detect a translocation in 8 of 12 cases that were negative by CE and four of eight negative by cytogenetic analysis. In conclusion, PFGE analysis is more comprehensive than CE, PCR, and cytogenetic analysis for the detection of the t(14;18) breakpoint in tissue biopsies of malignant lymphoma.

Entities:  

Mesh:

Substances:

Year:  1991        PMID: 1884022

Source DB:  PubMed          Journal:  Blood        ISSN: 0006-4971            Impact factor:   22.113


  14 in total

Review 1.  Somatic mosaicism: on the road to cancer.

Authors:  Luis C Fernández; Miguel Torres; Francisco X Real
Journal:  Nat Rev Cancer       Date:  2015-12-18       Impact factor: 60.716

Review 2.  Molecular pathology of low grade malignant lymphomas.

Authors:  H Ratech
Journal:  Med Oncol       Date:  1995-09       Impact factor: 3.064

3.  Altered B-cell receptor signaling kinetics distinguish human follicular lymphoma B cells from tumor-infiltrating nonmalignant B cells.

Authors:  Jonathan M Irish; Debra K Czerwinski; Garry P Nolan; Ronald Levy
Journal:  Blood       Date:  2006-07-11       Impact factor: 22.113

4.  Venetoclax plus R- or G-CHOP in non-Hodgkin lymphoma: results from the CAVALLI phase 1b trial.

Authors:  Andrew D Zelenetz; Gilles Salles; Kylie D Mason; Carla Casulo; Steven Le Gouill; Laurie H Sehn; Herve Tilly; Guillaume Cartron; Martine E D Chamuleau; Andre Goy; Constantine S Tam; Pieternella J Lugtenburg; Adam M Petrich; Arijit Sinha; Divya Samineni; Sylvia Herter; Ellen Ingalla; Edith Szafer-Glusman; Christian Klein; Deepak Sampath; Martin Kornacker; Mehrdad Mobasher; Franck Morschhauser
Journal:  Blood       Date:  2019-03-08       Impact factor: 22.113

5.  Crebbp loss cooperates with Bcl2 overexpression to promote lymphoma in mice.

Authors:  Idoia García-Ramírez; Saber Tadros; Inés González-Herrero; Alberto Martín-Lorenzo; Guillermo Rodríguez-Hernández; Dalia Moore; Lucía Ruiz-Roca; Oscar Blanco; Diego Alonso-López; Javier De Las Rivas; Keenan Hartert; Romain Duval; David Klinkebiel; Martin Bast; Julie Vose; Matthew Lunning; Kai Fu; Timothy Greiner; Fernando Rodrigues-Lima; Rafael Jiménez; Francisco Javier García Criado; María Begoña García Cenador; Paul Brindle; Carolina Vicente-Dueñas; Ash Alizadeh; Isidro Sánchez-García; Michael R Green
Journal:  Blood       Date:  2017-03-13       Impact factor: 22.113

6.  Hierarchy in somatic mutations arising during genomic evolution and progression of follicular lymphoma.

Authors:  Michael R Green; Andrew J Gentles; Ramesh V Nair; Jonathan M Irish; Shingo Kihira; Chih Long Liu; Itai Kela; Erik S Hopmans; June H Myklebust; Hanlee Ji; Sylvia K Plevritis; Ronald Levy; Ash A Alizadeh
Journal:  Blood       Date:  2013-01-07       Impact factor: 22.113

7.  Pulsed-field gel electrophoresis analysis of retinoic acid receptor-alpha and promyelocytic leukemia rearrangements. Detection of the t(15;17) translocation in the diagnosis of acute promyelocytic leukemia.

Authors:  Y H Xiao; W H Miller; R P Warrell; E Dmitrovsky; A D Zelenetz
Journal:  Am J Pathol       Date:  1993-11       Impact factor: 4.307

8.  Immunohistochemical analysis of Mcl-1 and Bcl-2 proteins in normal and neoplastic lymph nodes.

Authors:  S Krajewski; S Bodrug; R Gascoyne; K Berean; M Krajewska; J C Reed
Journal:  Am J Pathol       Date:  1994-09       Impact factor: 4.307

9.  ''Minor'' BCL2 breakpoints in follicular lymphoma: frequency and correlation with grade and disease presentation in 236 cases.

Authors:  Olga K Weinberg; Weiyun Z Ai; M Rajan Mariappan; Carol Shum; Ronald Levy; Daniel A Arber
Journal:  J Mol Diagn       Date:  2007-07-25       Impact factor: 5.568

Review 10.  Chromatin modifying gene mutations in follicular lymphoma.

Authors:  Michael R Green
Journal:  Blood       Date:  2017-11-20       Impact factor: 22.113

View more

北京卡尤迪生物科技股份有限公司 © 2022-2023.